A Complete Appraisal of Polymeric Micelle-Based Nanocarrier for Targeting Breast Cancer: Recent Strategies and Advancements

被引:0
作者
Ray, Supriya [1 ]
Singh, Dilpreet [1 ]
机构
[1] Chandigarh Univ, Univ Inst Pharm Sci, Dept Pharmaceut, Mohali 140413, India
关键词
Polymeric micelles; breast cancer therapy; drug delivery system; combination therapy; drug resistance; systemic toxicity; PLURONIC BLOCK-COPOLYMERS; DRUG-DELIVERY; IN-VITRO; MOLECULAR CLASSIFICATION; CO-DELIVERY; MACROMOLECULAR THERAPEUTICS; MAGNETIC MICELLES; MIXED MICELLES; BRAIN-TUMOR; DOXORUBICIN;
D O I
10.2174/0115748855302263240910060240
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim/Objective Polymeric micelle-based drug delivery systems have emerged as a beacon of hope in the challenging landscape of breast cancer therapy. This review aimed to explore the recent advancements and promising developments in the field, offering an in-depth analysis of their potential and challenges. The significance of this study lies in providing a comprehensive examination of the current advances in polymeric micelles technology, which have the potential to improve the efficiency and specificity of breast cancer therapy while minimizing adverse events.Methods Polymeric micelles offer a revolutionary therapy by encapsulating therapeutic agents, allowing for controlled drug release and the precise targeting of malignant cells, while lowering systemic toxicity. Recent advances have focused on enhancing targeting strategies, including active and passive targeting, to increase the specificity of polymeric micelle-based therapies. A systematic review of literature was carried out using databases, like PubMed, Scopus, and Web of Science, which included papers published between 2010 and 2023. The selection criteria of the literature focused on the drug-loading capabilities and targeting strategies of the polymeric micelles, which could be advantageous for breast cancer treatment.Results Clinical drug approaches leverage the versatility of micelles to co-deliver multiple agents, addressing the multifaceted nature of breast tumors and combating drug resistance. Additionally, polymeric micelles are finding applications in breast cancer diagnostics and imaging, enabling early detection and precise monitoring. The journey of polymeric micelle-based breast cancer therapy extends to formulation and engineering, preclinical and clinical studies, and confronts regulatory and commercialization challenges. However, the horizon is illuminated by emerging technologies, like personalized medicine, biomarker-driven targeting, and integration with novel therapies, promising a future where breast cancer treatment is tailored to individual patients and marked by improved efficacy and reduced side effects.Conclusion In conclusion, this review underscores the transformative potential of polymeric micelle-based delivery systems in breast cancer therapy.
引用
收藏
页数:21
相关论文
共 157 条
  • [21] Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers
    Batrakova, Elena V.
    Kabanov, Alexander V.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2008, 130 (02) : 98 - 106
  • [22] Bergh J, 2021, LANCET ONCOL, V22, P1139, DOI 10.1016/S1470-2045(21)00288-6
  • [23] Monitoring EPR Effect Dynamics during Nanotaxane Treatment with Theranostic Polymeric Micelles
    Biancacci, Ilaria
    De Lorenzi, Federica
    Theek, Benjamin
    Bai, Xiangyang
    May, Jan-Niklas
    Consolino, Lorena
    Baues, Maike
    Moeckel, Diana
    Gremse, Felix
    von Stillfried, Saskia
    El Shafei, Asmaa
    Benderski, Karina
    Shalmani, Armin Azadkhah
    Wang, Alec
    Momoh, Jeffrey
    Pena, Quim
    Buhl, Eva Miriam
    Buyel, Johannes
    Hennink, Wim
    Kiessling, Fabian
    Metselaar, Josbert
    Shi, Yang
    Lammers, Twan
    [J]. ADVANCED SCIENCE, 2022, 9 (10)
  • [24] PEGylated N-(2 hydroxypropyl) methacrylamide polymeric micelles as nanocarriers for the delivery of doxorubicin in breast cancer
    Bobde, Yamini
    Patel, Tarun
    Paul, Milan
    Biswas, Swati
    Ghosh, Balaram
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2021, 204
  • [25] Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Update
    Burstein, Harold J.
    Somerfield, Mark R.
    Barton, Debra L.
    Dorris, Ali
    Fallowfield, Lesley J.
    Jain, Dharamvir
    Johnston, Stephen R. D.
    Korde, Larissa A.
    Litton, Jennifer K.
    Macrae, Erin R.
    Peterson, Lindsay L.
    Vikas, Praveen
    Yung, Rachel L.
    Rugo, Hope S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (35) : 3959 - +
  • [26] Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]
  • [27] Block Copolymer Micelles in Nanomedicine Applications
    Cabral, Horacio
    Miyata, Kanjiro
    Osada, Kensuke
    Kataoka, Kazunori
    [J]. CHEMICAL REVIEWS, 2018, 118 (14) : 6844 - 6892
  • [28] Progress of drug-loaded polymeric micelles into clinical studies
    Cabral, Horacio
    Kataoka, Kazunori
    [J]. JOURNAL OF CONTROLLED RELEASE, 2014, 190 : 465 - 476
  • [29] Polymeric micelles: A novel drug delivery system for the treatment of breast cancer
    Chaudhuri, Aiswarya
    Ramesh, Korra
    Kumar, Dulla Naveen
    Dehari, Deepa
    Singh, Sanjay
    Kumar, Dinesh
    Agrawal, Ashish Kumar
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 77
  • [30] Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
    Chehelgerdi, Mohammad
    Chehelgerdi, Matin
    Allela, Omer Qutaiba B.
    Pecho, Renzon Daniel Cosme
    Jayasankar, Narayanan
    Rao, Devendra Pratap
    Thamaraikani, Tamilanban
    Vasanthan, Manimaran
    Viktor, Patrik
    Lakshmaiya, Natrayan
    Saadh, Mohamed J.
    Amajd, Ayesha
    Abo-Zaid, Mabrouk A.
    Castillo-Acobo, Roxana Yolanda
    Ismail, Ahmed H.
    Amin, Ali H.
    Akhavan-Sigari, Reza
    [J]. MOLECULAR CANCER, 2023, 22 (01)